lucatumumab chir human monoclonal antibody development discontinued novartis investigated treatment various types cancer like multiple myeloma follicular antagonist created scientists chiron using abgenix xenomouse transgenic mouse generate fully human made part collaboration chiron xoma companies commenced novartis took project acquired chiron vitro studies inhibited cell proliferation induced ligands induced cell three phase trials multiple myeloma chronic lymphocytic leukemia companies made effort determine optimal dose obtained unclear phase part planned phase iii trial multiple myeloma started updated phase ii closed results monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikilucatumumab